BunnHF. Drug-induced autoimmune red-cell aplasia. N Engl J Med2002; 346:522–3.
2.
FischP, HandgretingerR, SchaeferH. Pure red cell aplasia. Br J Haematol2000; 111:1010–22.
3.
CasadevallN, NatafJ, VironB, KoltaA, KiladjianJJ, Martin–DupontP. Pure red-cell aplasia and anti-erythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med2002; 346: 469–75.
4.
CasadevallN. Antibodies against rHuEPO: native and recombinant. Nephrol Dial Transplant2002; 17(Suppl 5):42–7.
5.
PorterSJ. Human immune response to recombinant human proteins. J Pharm Sci2001; 90:1–11.
6.
WeberG, GrossJ, KrommingsA, LoewHH, EckardtKU. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins. J Am Soc Nephrol2002; 13:2381–3.
7.
CastelliG, FamularoA, SeminoC, MachiAM, CeciA, CannellaG. Detection of anti-erythropoietin antibodies in haemodialysis patients treated with recombinant human-erythropoietin. Pharmacol Res2000; 41: 413–18.
